NCI Events

Featured Event

Tumor-Draining Lymph Nodes: Gaps and Opportunities Forum Series

Tumor-Draining Lymph Nodes: Gaps and Opportunities Forum Series

Event Date: January 13, 2026

This initiative will convene a monthly virtual forum series bringing together leading experts in lymph node biology, immunology, and cancer—from experimental scientists and clinicians to computational and in silico modelers—in a dynamic, interdisciplinary environment. 

Need an Event Site?

CBIIT Registration Events
CBIIT can assist you with building an event website hosted here at events.cancer.gov. Event websites include customized registrations, agendas, abstracts, speaker bios, and surveys. Event organizers have direct access to the information with the ability to edit content, export registration data and request automated email reminders. Site builds take a minimum of three weeks and all forms must have OMB clearance. Use the link below to request an event site.

Upcoming Events

(Displaying 6 out of 6 results)

December 2025

CCDI Webinar Series

CCDI Webinar Series

Event Date: December 9, 2025       Virtual

Throughout the year, CCDI will host open Community Forums, which highlight CCDI progress and what’s on the horizon for the initiative. These forums cover CCDI programs, such as the Rare Pediatric Cancer Initiative and the CCDI Participant Index.

January 2026

Cancer AI Conversations

Cancer AI Conversations

Event Date: January 4, 2026       Virtual Event

“Cancer AI Conversations” are bimonthly, 1-hour virtual events featuring timely topics related to the application of artificial intelligence in cancer research. Each event features short talks from 2-4 subject matter experts offering diverse perspectives on the session topic. These talks will be followed by a moderated panel discussion.

Tumor-Draining Lymph Nodes: Gaps and Opportunities Forum Series

Tumor-Draining Lymph Nodes: Gaps and Opportunities Forum Series

Event Date: January 13, 2026       Virtual Event

This initiative will convene a monthly virtual forum series bringing together leading experts in lymph node biology, immunology, and cancer—from experimental scientists and clinicians to computational and in silico modelers—in a dynamic, interdisciplinary environment. 

Fueling Cancer Progression by the Nervous System

Fueling Cancer Progression by the Nervous System

Event Date: January 22, 2026       Virtual Event

The Fueling Cancer Progression by the Nervous System series will feature six webinars, each exploring the junction between neuroscience and cancer biology to advance our understanding of cancer spread and metastatic colonization. Deciphering the interactions between the nervous system, cancer cells, and the host microenvironment brings key insights into molecular mechanisms of cancer progression and informs new treatment approaches.

February 2026

Consortium for Cancer Implementation Science Annual Meeting

Consortium for Cancer Implementation Science Annual Meeting

Event Date: February 25, 2026       Philadelphia, PA

The Consortium for Cancer Implementation Science (CCIS) annual meeting will be held in-person from February 25-27, 2026, in Philadelphia, Pennsylvania, hosted by the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania. This year’s meeting will feature engaging panel presentations, collaborative action group meetings, and an insightful poster session, all centered on the theme of: Advancing Implementation Science Across the Cancer Continuum from Prevention to Survivorship.

 

March 2026

Foundation Models for Cancer- Advancing Diagnosis, Prognosis, and Treatment Response

DCTD Workshop: Foundation Models for Cancer- Advancing Diagnosis, Prognosis, and Treatment Response

Event Date: March 24, 2026       Virtual

This virtual workshop, "Foundation Models for Cancer," will be held from March 24-26, 2026, between 10:00 AM and 2:00 PM EST. This workshop will explore how foundation models—a powerful class of advanced AI models —can transform cancer research and clinical care. We will focus on their potential to improve diagnosis, prognosis, and treatment response, with a strong emphasis on clinical translation and technology development.